Relationship between in vitro activities of amphotericin B and flucytosine and pH for clinical yeast and mold isolates

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 8, 2005, Pages 3341-3346

  Te Dorsthorst, D T A ^a,b   Verweij, P E ^b   Meis, J F G M ^a   Mouton, J W ^a  

^a CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

3 MORPHOLINOPROPANESULFONIC ACID; AMPHOTERICIN B; CITRIC ACID; FLUCYTOSINE; PHOSPHATE; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; ASPERGILLUS FUMIGATUS; CANDIDA; CRYPTOCOCCUS NEOFORMANS; DRUG ACTIVITY; FUNGUS ISOLATION; MINIMUM INHIBITORY CONCENTRATION; MOULD; NONHUMAN; PH; PRIORITY JOURNAL; RHIZOPUS; SCEDOSPORIUM; SCEDOSPORIUM PROLIFICANS; YEAST;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; BUFFERS; CANDIDA; CRYPTOCOCCUS NEOFORMANS; CULTURE MEDIA; FLUCYTOSINE; FUNGI; HYDROGEN-ION CONCENTRATION; MICROBIAL SENSITIVITY TESTS; RHIZOPUS; SCEDOSPORIUM;

EID: 23044500276     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.8.3341-3346.2005     Document Type: Article

References (16)

1. Abdul-Majid, K. B., P. A. Kenny, and J. J. Finlay-Jones. 1997. The effect of the bacterial product, succinic acid, on neutrophil bactericidal activity. FEMS Immunol. Med. Microbiol. 17:79-86.
2. Bryant, R. E., A. L. Rashad, J. A. Mazza, and D. Hammond. 1980. B-Lactamase activity in human pus. J. Infect. Dis. 142:594-601.
3. Ford, C. W., J. C. Hamel, D. Stapert, and R. J. Yancey. 1989. Establishment of an experimental model of a Staphylococcus aureus abscess in mice by use of dextran and gelatin microcarriers. J. Med. Microbiol. 28:259-266.
4. Kauffman, H. F., and K. de Vries. 1980. Antibodies against Aspergillus fumigatus. I. Standardization of the antigenic composition. Int. Arch. Allergy Appl. Immunol. 62:252-264.
5. Köning, C., H.-P. Simmen, and J. Blaser. 1998. Bacterial concentrations in pus and infected peritoneal fluid-implications for bactericidal activity of antibiotics. J. Antimicrob. Chemother. 42:227-232.
6. Meletiadis, J., J. W. Mouton, J. F. G. M. Meis, B. A. Bouman, P. J. Donnelly, P. E. Verweij, et al. 2001. Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis{2-methoxy-4-nitro-5- [(sulphenylamino)carbonyl]-2H-tetrazolium-hydroxide}, for antifungal susceptibility testing of Aspergillus species. J. Clin. Microbiol. 39:4256-4263.
7. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility of yeasts; approved standard-second edition. M27-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa.
8. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard. M38-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
9. Odds, F. C., C. E. Webster, and A. B. Abbott. 1984. Antifungal relative inhibition factors: BAY 1-9139, bifonazole, butonazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAYn-7133) compared in vitro with nine established antifungal agents. J. Antimicrob. Chemother. 14:105-114.
10. Rex, J. H., M. A. Pfaller, T. J. Walsh, V. Chaturvedi, A. Espinel-Ingroff, M. A. Ghannoum, L. L. Gosey, F. C. Odds, M. G. Rinaldi, D. J. Sheehan, and D. W. Warnock. 2001. Antifungal susceptibility testing: practical aspects and current challenges. Clin. Microbiol. Rev. 14:643-658.
11. Ruijter, G. J. G., C. P. Kubicek, and J. Visser. 2002. Production of organic acids by fungi, p. 213-230. In H. D. Osiewacz (ed.), The mycota X. Industrial applications. Springer, Berlin, Germany.
12. 2 and pH. Ann. Surg. 213:253-260.
13. Simmen, H.-P., and J. Blaser. 1993. Analysis of pH and pO2 in abscesses, peritoneal fluid, and drainage fluid in the presence or absence of bacterial infection during and after abdominal surgery. Am. J. Surg. 165:24-27.
14. te Dorsthorst, D. T. A., J. W. Mouton, C. J. P. van den Beukel, H. A. L. van der Lee, J. F. G. M. Meis, and P. E. Verweij. 2004. Effect of pH on the in vitro activities of amphotericin B, itraconazole, and flucytosine against Aspergillus isolates. Antimicrob. Agents Chemother. 48:3147-3150.
15. Viviani, M. A., M. C. Esposto, M. Cogliati, and A. M. Tortorano. 2003. Flucytosine and cryptococcosis: which in vitro test is the best predictor of outcome? J. Chemother. 15:124-128.
16. White, T. C., K. A. Marr, and R. A. Bowden. 1998. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11:382-402.